cancer patients<\/a>. <\/span><\/p>\nIn one study, 59% of colorectal cancer patients were vitamin D deficient, compared to about 15% of the general population; low levels were associated with a poorer prognosis.<\/span><\/p>\nThe scientific evidence for vitamin D in oncology has grown significantly in recent years. Several large meta-analyses of randomized studies show that daily administration of vitamin D3 can reduce cancer mortality by approximately 12%. This effect was observed primarily with daily intake, not with high-dose intervals. <\/span><\/p>\nThe benefit was also greatest in people over the age of 70 and when vitamin D supplementation was started before the diagnosis was made. <\/span><\/p>\nImportant: <\/b>Although vitamin D is unlikely to prevent cancer, it may improve survival and treatment outcomes.<\/span><\/p>\nThere are also indications of benefits for specific tumor types: patients with breast cancer or those with colorectal cancer or aggressive lymphomas had a better prognosis in observational studies if their vitamin D levels were higher. Therefore, it is recommended to definitely check vitamin D status in these diagnoses and specifically address any deficiency. <\/span><\/p>\nIn practice, this often means taking vitamin D3 drops or capsules for several weeks until an adequate blood level is reached. An optimal target serum value is usually stated in the range of 30\u201350 ng\/ml 25(OH)Vitamin D3, depending on the guideline. <\/span><\/p>\nVitamin D is considered safe in appropriate doses; overdoses should be avoided, but rarely occur with sensible supplementation. In summary, a good supply of vitamin D can be considered an important component in strengthening the immune system of tumor patients and possibly positively influencing the course of the disease. <\/span><\/p>\n <\/p>\n
\n- \n
Vitamin C<\/b><\/h3>\n<\/li>\n<\/ul>\n
Vitamin C (ascorbic acid) is a central antioxidant in the body and supports numerous immune functions. For example, it increases the activity of phagocytes and natural killer cells and protects tissues from oxidative stress caused by free radicals. <\/span><\/p>\nVitamin C is much discussed in cancer therapy, as high-dose vitamin C can selectively damage tumor cells in laboratory tests, while it is tolerated by normal cells. However, the evidence from clinical studies is still limited. What do current data say? <\/span><\/p>\nThere is reassuring news for moderate doses as a dietary supplement: An evaluation of breast cancer patients found no disadvantages from taking vitamin C from the time of diagnosis – on the contrary, the results even indicated an improved overall and breast cancer-specific survival benefit . <\/span><\/p>\nHowever, it was important that the dose remained within reasonable limits: over 500 mg\/day should not be taken without further ado, as very high doses could theoretically impair the effectiveness of chemotherapy or radiotherapy. <\/span><\/p>\nVitamin C in normal supplement doses (e.g. 200-500 mg daily), on the other hand, is considered safe and was associated with better outcomes in the study mentioned.<\/span><\/p>\nThe situation is different with infused high-dose vitamin C: here, sometimes 7.5 to 30 grams of ascorbic acid are given intravenously. Some oncologists in complementary medicine use this to combat fatigue (chronic exhaustion) \u2013 with quite positive patient feedback. <\/span><\/p>\nIndeed, many affected individuals report that high-dose intravenous vitamin C improves their energy and quality of life. However, large randomized studies clearly demonstrating a benefit are still lacking. The simultaneous administration of high-dose vitamin C during chemotherapy is also controversial and not generally recommended. <\/span><\/p>\nSome experts advise that infusions should only be administered after chemotherapy (e.g. a few days apart) in order to avoid possible interactions. Caution is therefore required here and individual medical advice is essential. <\/span><\/p>\nTo summarize:<\/b> Vitamin C is an important immune nutrient; in normal amounts it supports the immune system and does no harm – with extreme doses, however, the benefits and risks should be carefully weighed up and action should only be taken in consultation with specialists.<\/span><\/p>\n <\/p>\n
\n- \n
Zinc<\/b><\/h3>\n<\/li>\n<\/ul>\n
Zinc is one of the essential trace elements and is involved in over 300 enzymatic reactions in the body \u2013 many of which are crucial for the immune system. Zinc is needed, for example, for the maturation of immune cells (T-lymphocytes), for the production of antibodies and cytokines, and for wound healing. <\/span><\/p>\nZinc deficiency leads to a reduced immune system and increases susceptibility to infections; even a slight zinc deficiency can lead to more frequent infections, as studies on various population groups have shown. <\/span><\/p>\nZinc deficiency is not uncommon in cancer patients – on the contrary, recent studies indicate that zinc deficiency can occur in practically all types of tumors. <\/span><\/p>\nA recent Israeli review found that zinc deficiency in cancer patients correlates with disease severity and survival rates. In other words: Low zinc levels were often associated with more aggressive courses and poorer prognosis. <\/span><\/p>\nIt is noteworthy that zinc showed direct tumor-inhibiting effects in laboratory and animal studies – the review mentioned above reports a surprising cytotoxicity towards cancer cells without damaging healthy cells. <\/span><\/p>\nThis effect was observed across different types of cancer. Of course, such results should be interpreted with caution, but they underline the potential importance of zinc. The author of the study recommends ensuring that all oncology patients have an adequate zinc supply and supplementing zinc if necessary. <\/span><\/p>\nIn practice, zinc (usually as zinc histidine, zinc orotate, or similar) is often given in dosages of 25\u201350 mg per day if a deficiency exists. Typical benefits of zinc in complementary oncology include improved wound healing (e.g., after surgery), support for mucous membranes (e.g., in mucositis or after radiation), and a general increase in infection defense. <\/span><\/p>\nZinc can prevent or reduce taste disorders (a common side effect of chemotherapy), as zinc is important for taste bud regeneration. <\/span><\/p>\nOverall, zinc is considered safe and well tolerated as long as you do not take far more than 50 mg daily (extremely high doses over a long period of time could unbalance other trace elements such as copper). <\/span><\/p>\nZinc status can be determined in serum or whole blood; in the case of a manifest deficiency, it should be substituted. Zinc is therefore another key factor for a strong immune system in cancer therapy – the data at least supports the approach of avoiding a deficiency at all costs. <\/span><\/p>\n <\/p>\n
\n- \n
B vitamins<\/b><\/h3>\n<\/li>\n<\/ul>\n
B vitamins form an entire group of eight water-soluble vitamins (B1, B2, B3, B5, B6, B7, B9, B12) that cooperate closely in metabolism. They are primarily indispensable for energy production in cells, nerve function, and blood formation. <\/span><\/p>\nIn oncology, vitamin B1 (thiamine), vitamin B6 (pyridoxine), folic acid (B9), and vitamin B12 (cobalamin) are of particular interest. Why? Firstly, certain chemotherapies can increase the need for B vitamins or disrupt their utilization (methotrexate, for example, blocks folate metabolism, which is why folate rescue is necessary). <\/span><\/p>\nOn the other hand, many cancer patients suffer from a loss of appetite or malnutrition, which can lead to B vitamin deficiencies.<\/span><\/p>\nVitamin B12 and folic acid are essential for the formation of red blood cells. A deficiency can cause anemia (blood deficiency), which exacerbates the already common therapy-related anemia \u2013 resulting in fatigue, weakness, and concentration problems. <\/span><\/p>\nEqually important:<\/b> B12 and folate are needed for functioning DNA synthesis and cell division; low levels can contribute to genetic instability. <\/span> <\/p>\nVitamins B1 and B6 are central for the nerves: thiamine deficiency, for example, can lead to peripheral neuropathies (nerve disorders in legs\/hands). Interestingly, one of the feared side effects of some chemotherapies (e.g., with taxanes or platinum-based drugs) is also polyneuropathy. Here, it is discussed whether the supplementation of B vitamins (especially B1, B6, B12) could have a protective effect. <\/span><\/p>\nSome studies show that the administration of vitamin E and B12 can reduce the severity of chemoneuropathies, while other results are inconsistent. In any case, care should be taken to ensure an adequate supply of these vitamins to prevent or mitigate nerve damage. <\/span><\/p>\nVitamin B6 (pyridoxine) is often given prophylactically in oncology, e.g. to alleviate hand-foot syndrome under certain chemotherapies (such as 5-FU or capecitabine). <\/span><\/p>\nVitamin B1 could contribute to the alleviation of chemo-induced neurotoxicities, as case reports suggest. Niacin (B3) and riboflavin (B2) play a role in skin and mucous membrane function – deficiencies here should also be avoided in order not to aggravate inflammation of the mucous membranes, for example. <\/span><\/p>\n <\/p>\n
To summarize: <\/b>While B vitamins are not direct “cancer killers,” they ensure that the body copes better with therapy. They help against fatigue (chronic tiredness) \u2013 a B vitamin deficiency can cause tiredness and weakness \u2013 and support nerves, blood formation, and mucous membranes. <\/span><\/p>\nTypically, B vitamins are administered as part of restorative preparations or multivitamin infusions, often combined, as they act synergistically. Supplementation should be based on individual needs (e.g., measuring vitamin B12 levels, especially with vegetarian\/vegan diets or absorption disorders). <\/span><\/p>\nExtreme overdoses should be avoided, as very high doses of B6 and B12, for example, have been associated with an increased risk of lung cancer in smokers in individual cases. In normal amounts, however, B vitamins are safe and an important component of orthomolecular support. <\/span><\/p>\n <\/p>\n
\n- \n
Curcumin and phytochemicals<\/b><\/h3>\n<\/li>\n<\/ul>\n
Curcumin is the yellow active ingredient from the turmeric root and belongs to the phytochemicals, specifically polyphenols. It is known for its anti-inflammatory and antioxidant properties. <\/span><\/p>\nIn cancer research, curcumin is considered a promising candidate, as it has shown diverse anti-tumor effects in laboratory and animal studies. For example, in cell culture studies, curcumin was able to kill cancer cells or stop their growth and influence signaling pathways involved in tumor growth and metastasis. <\/span><\/p>\nIn mouse models, it has been observed that curcumin can increase the effectiveness of certain chemotherapies and protect healthy cells from radiation damage. These findings raise hopes that curcumin can be used as a supplement in cancer therapy, e.g. to enhance the effect of chemo-immunotherapies or to reduce inflammatory processes in tumor tissue. <\/span><\/p>\nHowever, clinical studies in humans are still in early phases. While several clinical studies are underway (some with curcumin capsules in patients with colorectal cancer, pancreatic cancer, etc.), clear results are not yet available. <\/span><\/p>\nTherefore, the current consensus is: <\/b>Curcumin cannot currently be recommended as a standalone cancer medication. Nevertheless, many experts speak of high potential \u2013 especially because curcumin is relatively well tolerated. <\/span><\/p>\nSome oncologists use it as a complementary measure, especially for colon cancer (as it can act locally in the intestine) or to inhibit inflammation in dermatitis caused by radiotherapy.<\/span><\/p>\nIn addition to curcumin, there are a number of other secondary plant substances with potentially oncologically relevant effects: resveratrol (from red grapes), EGCG (green tea extract), sulforaphane (broccoli extract) or quercetin (from onions\/apples) are examples. <\/span><\/p>\nMany of them act as antioxidants and modulate signaling pathways that are important for cancer cells. Artemisinin (mugwort extract) and cannabinoids (e.g. CBD) are also being investigated and are already being used in some cases, for example to alleviate side effects such as nausea. <\/span><\/p>\n <\/p>\n
Important for all these phytotherapeutics: <\/b>One should be aware of their interactions with conventional therapies. Curcumin, for example, should not be given simultaneously with certain chemotherapeutic agents like taxanes, as it could affect their metabolic pathways. <\/span><\/p>\nGreen tea extracts should also not be taken in parallel with bortezomib (a myeloma drug), as they can counteract its effect \u2013 this was discovered in cell experiments. St. John’s wort (though not a “micronutrient,” but a plant substance) can influence liver enzymes in such a way that chemotherapy drugs are broken down more quickly. <\/span><\/p>\nTherefore: <\/b>Only use secondary plant substances in consultation with your doctor! However, if selected and dosed correctly, they can have an anti-inflammatory effect, support the immune system and alleviate symptoms without interfering with conventional therapy. <\/span><\/p>\nCurcumin itself is often used as an anti-inflammatory adjuvant – for example, some patients report less joint pain or better digestion with turmeric preparations. <\/span><\/p>\nHowever, the oral bioavailability of curcumin is low, which is why there are special formulations (with pepper extract, liposomes, etc.) to increase absorption. In summary, curcumin and co. are an exciting area of complementary cancer therapy that continues to be the subject of intensive research. When used correctly, they can enrich the overall therapeutic concept – but they are not a panacea and they do not replace proven oncological therapies. <\/span><\/p>\n <\/p>\n
Alleviation of side effects through orthomolecular therapy<\/b><\/h2>\n
One of the main aims of complementary oncology is to reduce the side effects of therapy and improve quality of life. Many of the micronutrients mentioned above are used specifically for this reason. Here are some important examples of how orthomolecular support can help with typical side effects: <\/span><\/p>\n\n- Fatigue (tumor-related exhaustion):<\/strong> Cancer-related fatigue and tiredness are among the most common complaints of patients undergoing chemo or radiation therapy. Here, iron (for anemia), vitamin D (for deficiency), B12\/folic acid, and also L-carnitine can be helpful. <\/span>
\n<\/span>L-carnitine is not a vitamin, but a vitamin-like nutrient required for energy production in the mitochondria. Studies with cancer patients \u2013 especially in the field of gynecological tumors \u2013 show that L-carnitine administration can improve fatigue. Similarly, high-dose intravenous vitamin C is successfully used against fatigue in some concepts. <\/span>
\n<\/span>It is important to rule out other causes beforehand (e.g. hypothyroidism, severe anemia) and to adapt the measures individually.<\/span><\/li>\n<\/ul>\n <\/p>\n
\n- Susceptibility to infection:<\/strong> Chemotherapy often leads to leukopenia (a lack of white blood cells) and a weakening of the immune defense against infections. Zinc and selenium play a key role here. Selenium supplementation has been shown in studies to reduce the rate of severe infections and febrile neutropenia. <\/span>
\n<\/span>Zinc promotes the formation and maturation of immune cells – a good zinc status can help to prevent or mitigate respiratory and urinary tract infections. <\/span>
\n<\/span>Vitamin C also slightly shortens the duration of colds if you are susceptible to infections and vitamin D has been shown to reduce the risk of respiratory infections, which also indirectly helps cancer patients, e.g. to avoid treatment-delaying infections during chemotherapy. <\/span>
\n<\/span>In certain cases, immunoglobulin substitution is also considered, but this is not part of orthomolecular medicine in the narrow sense, but of conventional medicine.<\/span><\/li>\n<\/ul>\n <\/p>\n
\n- Mucositis (inflammation of the mucous membranes):<\/strong> Both chemotherapy and radiation (especially in the head and neck area) often cause painful inflammation of the oral and intestinal mucosa. <\/span>
\n<\/span>Various nutrients have proven useful here. Glutamine, an amino acid, can promote the healing of oral mucosa when given orally. Zinc lozenges show a benefit in some studies for preventing oral mucositis. Very interesting: vitamin D deficiency promotes the occurrence of mucositis and taste disorders during chemotherapy, as one study reported. <\/span>
\n<\/span>A good vitamin D level could therefore make the mucous membranes more resilient. Selenium has also been linked to less severe mucositis \u2013 possibly due to its antioxidant cell-protective effect. <\/span>
\n<\/span>Finally, vitamin B12 helps with the regeneration of the oral mucosa; a B12 deficiency is often partly responsible for aphtous stomatitis (a type of inflammation of the oral mucosa). <\/span>
\n<\/span>Cool mouthwashes with tea (sage, camomile), honey (medicinal manuka honey can reduce inflammation) and aloe vera juice have also proven effective in relieving acute mucositis – although these are more phytotherapeutic approaches.<\/span><\/li>\n<\/ul>\n <\/p>\n
\n- Neuropathy (nerve damage):<\/strong> Some chemotherapies (e.g. oxaliplatin, vincristine, taxanes) lead to tingling, numbness or pain in the hands and feet. <\/span>
\n<\/span>Orthomolecular approaches attempt to counteract this with vitamin E, vitamins B1\/B6\/B12, and sometimes alpha-lipoic acid. A systematic review found evidence that high-dose vitamin E can reduce the incidence of severe polyneuropathies. <\/span>
\n<\/span>B vitamins have already been mentioned \u2013 they nourish the peripheral nerves. Alpha-lipoic acid (an antioxidant) is known from diabetes treatment for neuropathic complaints and is also occasionally tested for chemotherapy-induced neuropathy. <\/span>
\n<\/span>Results are mixed, but worth a try if approved by the doctor. It is also important to have good pain therapy and physiotherapy for existing nerve damage – orthomolecular agents can provide support, but in severe cases cannot provide relief on their own. <\/span><\/li>\n<\/ul>\n <\/p>\n
\n- Nausea and loss of appetite: <\/b>In addition to classic medication (antiemetics), vitamin B6 and ginger extract are often used here. Vitamin B6 in doses of 50\u2013100 mg\/day can slightly alleviate chemotherapy-induced nausea and is also given to pregnant women for nausea. <\/span>
\n<\/span>Ginger is a phytotherapeutic agent whose effectiveness against nausea has been proven in studies. <\/span>
\n<\/span>Although it is not a micronutrient, it should be mentioned that ginger preparations are often included in integrative concepts (e.g. ginger capsules before chemotherapy). <\/span>
\n<\/span>Zinc supports the sense of taste – patients with loss of taste and lack of appetite may benefit from zinc supplements because food tastes better again.<\/span><\/li>\n<\/ul>\n <\/p>\n
To summarize: <\/b>Many side effects of cancer therapy can be alleviated by targeted orthomolecular concomitant treatment. <\/span> <\/p>\nThis does not mean that they disappear completely – but often the tolerability of chemotherapy or radiotherapy is significantly increased, which in turn helps patients to adhere to the planned therapy cycles and reduces the need for dose reductions. <\/span><\/p>\nSupportive therapy with micronutrients thus makes an indirect contribution to the success of the therapy because it allows the patient to undergo the main treatment more vigorously and with fewer interruptions.<\/span><\/p>\n <\/p>\n
Laboratory-supported supplementation: customized nutrient therapy<\/b><\/h2>\n
Every person is different \u2013 and so are the individual micronutrient needs of cancer patients. A central principle of orthomolecular medicine is therefore lab-supported supplementation. <\/span><\/p>\nBefore blindly taking vitamin pills, one should measure what is actually needed. Blood tests can provide information about, for example, vitamin D levels, selenium or zinc concentrations in whole blood, B12 levels, folic acid, ferritin (iron), and other parameters. <\/span><\/p>\nSupplementation can then be targeted and personalized on the basis of these laboratory values. This prevents unnecessary or even harmful overdoses and strengthens those nutrients for which there is a real deficit or additional requirement. <\/span><\/p>\nAn example: Vitamin D. Here, the 25(OH)D value in serum should be determined before high-dose supplementation. If it is significantly reduced, an initial loading dose can be administered, followed by a maintenance dose\u2014until the level is within the target range. <\/span><\/p>\nAfter that, a lower dose is often sufficient for maintenance. For selenium, the level (e.g., whole blood selenium) can be measured; however, interpretation is complex, as reference ranges vary. <\/span><\/p>\nSelenium deficiency is relatively common in Germany, as the soil is low in selenium. A moderate substitution (e.g. 100-200 \u00b5g sodium selenite daily) can be useful here, but ideally controlled via laboratory after a few weeks so as not to get into a potentially unhealthy excess range. <\/span><\/p>\nLaboratory diagnostics are also important to check the success of supplementation. For example, if a cancer patient undergoing chemotherapy suffers from severe magnesium deficiency (e.g., due to platinum-containing drugs that increase renal magnesium excretion), then magnesium will be administered, and subsequently, it will be checked whether the values are normal again. <\/span><\/p>\nThe same applies to zinc: an initial deficiency should be remedied after a few months of supplementation – if not, the dose or form must be adjusted (or compliance checked).<\/span><\/p>\nThis individual, data-supported approach makes orthomolecular medicine a serious personalized supplement therapy. <\/span><\/p>\n